Autres langues Diaceutics PLC

Actions

DXRX

GB00BJQTGV64

Services d'assistance aux entreprises

Temps Différé London S.E. 12:21:36 02/09/2026			Varia. 5j.	Varia. 1 janv.
144,77 ^GBX	-1,85 %		-1,85 %	+13,10 %

20/08	Diaceutics et le Precision Cancer Consortium lancent une étude de concordance NGS pour faire progresser l'oncologie de précision et soutenir le dépistage éclairé des biomarqueurs	CI
02/06	Transcript : Diaceutics PLC, 2025 Earnings Call, May 26, 2026

Autres langues

20/08	Diaceutics and Precision Cancer Consortium Launch Ngs Concordance Study to Advance Precision Oncology and Support Informed Biomarker Testing
29/07	Diaceutics PLC Reports Revenue Results for the Half Year Ended 30 June 2026
26/05	Diaceutics PLC Reports Earnings Results for the Full Year Ended December 31, 2025
26/05	Diaceutics says order book and pipeline provides confidence for 2026
26/05	Diaceutics says Q1 2026 performance in line with board's expectations
26/05	Earnings Flash (DXRX.L) Diaceutics PLC Reports FY25 Revenue GBP38.4M
06/02	Hargreave Hale AIM asset value falls after "eventful" first quarter
15/01	TruFin lifts outlook, Abingdon reports revenue gain
15/01	Diaceutics PLC Provides Earnings Guidance for the Year Ended December 31, 2025 and Fiscal Year 2026
15/01	Diaceutics expects to deliver 25% revenue growth in FY26
23/09/25	EARNINGS AND TRADING: Smiths News eyes profit beat; Fonix revenue up
23/09/25	Diaceutics PLC Reports Earnings Results for the Half Year Ended June 30, 2025
29/07/25	Diaceutics PLC Appoints Lauren Dewitt as Executive Vice President, Legal, General Counsel, and Group Company Secretary
22/07/25	Diaceutics stock rises on "strong" first half and contract expansion
22/07/25	Diaceutics reports 22% revenue growth to £14.6 mln in HY
17/07/25	Diaceutics plc Expands PMx Commercialization Partnership Contract
10/07/25	Jefferies cuts Landsec and British Land
19/05/25	Diaceutics chair sells 500,000 shares after results release
16/05/25	Diaceutics plc Announces Termination of Sally Craig as Secretary or Corporate Secretary, Effective May 5, 2025
13/05/25	Diaceutics narrows loss, grows revenue in "another strong year"
13/05/25	Diaceutics Says Do Not Expect Direct Impact From Recent Tariff Announcements
13/05/25	Earnings Flash (DXRX.L) DIACEUTICS Reports FY24 Revenue GBP32.2M
13/05/25	Earnings Flash (DXRX.L) DIACEUTICS Reports FY24 Loss GBX-2.02
13/05/25	Diaceutics PLC Reports Earnings Results for the Full Year Ended December 31, 2024
05/05/25	Diaceutics plc Announces Appointment of Nicholas Stewart Roberts as Secretary, Effective May 5, 2025